| Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger … D Grimwade, RK Hills, AV Moorman, H Walker, S Chatters, AH Goldstone, ... Blood, The Journal of the American Society of Hematology 116 (3), 354-365, 2010 | 2260 | 2010 |
| Genetic variegation of clonal architecture and propagating cells in leukaemia K Anderson, C Lutz, FW Van Delft, CM Bateman, Y Guo, SM Colman, ... Nature 469 (7330), 356-361, 2011 | 1034 | 2011 |
| Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council … AV Moorman, CJ Harrison, GAN Buck, SM Richards, LM Secker-Walker, ... Blood 109 (8), 3189-3197, 2007 | 861 | 2007 |
| Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised … RK Hills, S Castaigne, FR Appelbaum, J Delaunay, S Petersdorf, M Othus, ... The lancet oncology 15 (9), 986-996, 2014 | 805 | 2014 |
| Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia LJ Russell, M Capasso, I Vater, T Akasaka, OA Bernard, MJ Calasanz, ... Blood, The Journal of the American Society of Hematology 114 (13), 2688-2698, 2009 | 611 | 2009 |
| Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial AV Moorman, HM Ensor, SM Richards, L Chilton, C Schwab, SE Kinsey, ... The lancet oncology 11 (5), 429-438, 2010 | 532 | 2010 |
| T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993) DI Marks, EM Paietta, AV Moorman, SM Richards, G Buck, G DeWald, ... Blood, The Journal of the American Society of Hematology 114 (25), 5136-5145, 2009 | 467 | 2009 |
| UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia AK Fielding, JM Rowe, G Buck, L Foroni, G Gerrard, MR Litzow, ... Blood, The Journal of the American Society of Hematology 123 (6), 843-850, 2014 | 436 | 2014 |
| Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12 CJ Harrison, RK Hills, AV Moorman, DJ Grimwade, I Hann, DKH Webb, ... Journal of clinical oncology 28 (16), 2674-2681, 2010 | 407 | 2010 |
| Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial C Parker, R Waters, C Leighton, J Hancock, R Sutton, AV Moorman, ... The Lancet 376 (9757), 2009-2017, 2010 | 394 | 2010 |
| Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation … AK Fielding, JM Rowe, SM Richards, G Buck, AV Moorman, IJ Durrant, ... Blood, The Journal of the American Society of Hematology 113 (19), 4489-4496, 2009 | 366 | 2009 |
| Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute … A Vora, N Goulden, C Mitchell, J Hancock, R Hough, C Rowntree, ... The lancet oncology 15 (8), 809-818, 2014 | 358 | 2014 |
| Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia JM Allan, CP Wild, S Rollinson, EV Willett, AV Moorman, GJ Dovey, ... Proceedings of the National Academy of Sciences 98 (20), 11592-11597, 2001 | 345 | 2001 |
| The genetic basis and cell of origin of mixed phenotype acute leukaemia TB Alexander, Z Gu, I Iacobucci, K Dickerson, JK Choi, B Xu, ... Nature 562 (7727), 373-379, 2018 | 342 | 2018 |
| RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years DT Bowen, ME Frew, R Hills, RE Gale, K Wheatley, MJ Groves, ... Blood 106 (6), 2113-2119, 2005 | 334 | 2005 |
| Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group TD Buitenkamp, S Izraeli, M Zimmermann, E Forestier, NA Heerema, ... Blood, The Journal of the American Society of Hematology 123 (1), 70-77, 2014 | 323 | 2014 |
| Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ... Nature genetics 42 (6), 492-494, 2010 | 320 | 2010 |
| Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia Y Li, C Schwab, SL Ryan, E Papaemmanuil, HM Robinson, P Jacobs, ... Nature 508 (7494), 98-102, 2014 | 318 | 2014 |
| Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia Z Gu, M Churchman, K Roberts, Y Li, Y Liu, RC Harvey, K McCastlain, ... Nature communications 7 (1), 13331, 2016 | 307 | 2016 |
| A population-based cytogenetic study of adults with acute lymphoblastic leukemia AV Moorman, L Chilton, J Wilkinson, HM Ensor, N Bown, SJ Proctor Blood, The Journal of the American Society of Hematology 115 (2), 206-214, 2010 | 305 | 2010 |
Christine J HarrisonNewcastle UniversityAdresse e-mail validée de newcastle.ac.uk
